Objective outcome measures | Subjective outcome measures | Metabolic measures | Data collection points, duration of intervention | Cultural consultation and adaption | |
---|---|---|---|---|---|
Biddle et al. [48] | Vo2 peak**↑, leg strength (maximal quadriceps at 60deg/second)*↑ | PAR-Q | Fasting glucose and glycated haemoglobin (HbA1c), lipid profile (HDL)*↑, blood pressure and C-reactive protein | Baseline, 4 weeks, IP | Community consultations |
Canuto et al. [49] | Height, weight*↓, BMI*↓, waist and hip circumference, and blood pressure, Step count [data not shown] | Sallis seven-day physical activity recall survey (1985), Quality of life (SF36) | Fasting venous samples of glucose and serum insulin, total cholesterol, high-density lipoprotein (HDL) and triglyceride concentration. HbA1c and c-reactive protein | Baseline, 12 weeks, IP, 12WP, | Community consultations |
Chan et al. [43] | Weight, Waist*↓ and hip circumference, Blood pressure*↓, Step count | Plasma glucose (fasting), HbA1c*↓, Lipid profile*↓ (LDL cholesterol, HDL cholesterol, triglycerides*↓, Homocysteine, C-peptide, Serum creatinine, Microalbuminuria, Insulin resistance, Triglyceride, Homocysteine levels | Baseline, 6 months | Community consultations | |
Coppell et al. [50] | Weight, waist circumference, blood pressure*↓, BMI | Medical history, self-reported physical activity*↑ and dietary behaviours**↑↓ (New Zealand Health Survey, 1999). | 75g fasted oral glucose tolerance test (OGTT)*↑, Fasting insulin, fasting lipids ↓*and urate*↓ and a mid-stream urine sample*↑. | Baseline, ongoing, two years post intervention | Community consultations |
Davey et al. [40] | Age, gender, health conditions, Weight*↓, BMI*↓, waist circumference *↓, 6 minute walk test (6MWT)*↑, Incremental shuttle walk test (ISWT)*↑, Timed Up and Go (TUG)*↓ | Chronic Respiratory Questionnaire (CRQ), Quality of life (SF36)*↑ | Baseline, 8 weeks, IP | Community consultations | |
Dimer et al. [51] | Weight, BMI*↓, 6 minute walk test (6MWT)**↑, Blood pressure*↓, Waist girth**↓ | Baseline, 8 weeks, IP | Community consultation | ||
Egger et al. [42] | Weight**↓, Waist & hip circumference (cm)**↓, BMI**↓, hip circumference **↓, Waist to hip ratio, Body fat through bio-impedance analysis**↓., fat mass (kg)**↓ | 1 year follow up | Community consultation | ||
Gracey et al. [52] † | Weight, BMI, Blood pressure | HbA1c, glucose, cholesterol (total, LDL, HDL), triglycerides | Not specified | Community consultation | |
McAuley et al. [36] | Weight**↓, height, waist and hip circumference**↓, blood pressure*↓, BMI**↓, Body composition (fat free mass)*↓, and submaximal exercise test (one mile walk test)**↑ | 4 day diet record pre and post intervention and a daily diet record. *↓ PAR-Q Physical activity levels: Based on the Life in New Zealand (LINZ) | fasting insulin, glucose**↓, and lipids, insulin sensitivity**↓ | Baseline, 4 months, IP | Community consultation |
Mendham et al. [41] | Body mass*↓, blood pressure, waist circumference*↓ (WC) and hip circumference, BMI*↓ A graded exercise test (GXT)*↑ to determine peak oxygen consumption (VO2 peak) and maximal aerobic workload (Wmax) | PAR-Q | Leptin (pg mL−1)**↓, Glucose regulation: Fasting glucose test and oral glucose tolerance test (OGTT), Inflammatory markers: C-reactive proteins and inflammatory cytokines. Matsuda ISI (μlUmL−1, mg mL−1)*↑, HOMA-IR (μlUmL−1, mg mL−1)*↑ | Baseline, 12 weeks, IP | Community consultation |
O’Dea [39] | Weight, BMI | Physical activity levels on a scale of 1–5. | Oral glucose tolerance test*↓, fasting plasma insulin *↓Plasma triglycerides*↓ , plasma cholesterol Fasting plasma glucose*↓ | Baseline, 7 weeks, IP | Unsure |
Rowley et al. [35]♦ | Body weight, BMI**↓ | Diet and physical activity questionnaires [not specified] | 75g oral glucose tolerance test (OGTT)**↓, Fasting plasma triglyceride*↓ and insulin concentrations*↑ Fasting plasma glucose *↓ | Baseline, 6M, 12M, 18M, 24M, 48M | Community consultation |
Sukala et al. [53] | Weight, BMI, Blood pressure | SF36 (Quality of Life)*↑ | Baseline, 16 weeks, IP | Community consultation |